
Apretero 125/80mg Tab
Price:
Get Latest Price
In Stock
Product Specifications
Dosage | 125/80mg |
Form | Capsules |
Manufacturer | Hetero Labs |
Packaging | Blister pack |
Storage | Cool, dry |
Usage | Chemotherapy-induced nausea and vomiting prevention, postoperative nausea and vomiting prevention. |
Expiry | 2 years |
Features | Antiemetic, NK1 antagonist, CINV prevention, Post-op nausea relief |
Product Overview
Key Features
We are the popular exporter, distributor, supplier and trader of apretero 125/80mg tab in Kurnool, Andhra Pradesh, India. Is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor. Aprepitant is manufactured by Merck & Co. under the brand name Emend for prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and for prevention of postoperative nausea and vomiting.
Aprepitant may also be useful in the treatment of cyclic vomiting syndrome & late-stage chemotherapy induced vomiting, but there are few studies to date
Aprepitant is classified as an NK1 antagonist because it blocks signals given off by NK1 receptors. This, therefore, decreases the likelihood of vomiting in patients.
NK1 is a G protein-coupled receptor located in the central and peripheral nervous system. This receptor has a dominant ligand known as Substance P (SP). SP is a neuropeptide, composed of 11 amino acids, which sends impulses and messages from the brain. It is found in high concentrations in the vomiting center of the brain, and, when activated, it results in a vomiting reflex. In addition to this it also plays a key part in the transmission of pain impulses from the peripheral receptors to the central nervous system.
Aprepitant may also be useful in the treatment of cyclic vomiting syndrome & late-stage chemotherapy induced vomiting, but there are few studies to date
Aprepitant is classified as an NK1 antagonist because it blocks signals given off by NK1 receptors. This, therefore, decreases the likelihood of vomiting in patients.
NK1 is a G protein-coupled receptor located in the central and peripheral nervous system. This receptor has a dominant ligand known as Substance P (SP). SP is a neuropeptide, composed of 11 amino acids, which sends impulses and messages from the brain. It is found in high concentrations in the vomiting center of the brain, and, when activated, it results in a vomiting reflex. In addition to this it also plays a key part in the transmission of pain impulses from the peripheral receptors to the central nervous system.
Company Details
VISWABHARATHI PHARMA, Established in 2009 at Kurnool in Andhra Pradesh, is a leading Exporter,Distributor,Supplier,Trading Company,Wholesaler of Pain Relief Drugs & Medicines in India. VISWABHARATHI PHARMA is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading Apretero 125/80mg Tab, VISWABHARATHI PHARMA has made a reputed name for itself in the market with high-quality Anastrozole Tablet, Apretero 125/80mg Tab, Capecitabine Tablet, etc.
Focusing on a customer-centric approach, VISWABHARATHI PHARMA has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pain Relief Drugs & Medicines in bulk from VISWABHARATHI PHARMA at Trade India quality-assured products.
Focusing on a customer-centric approach, VISWABHARATHI PHARMA has a pan-India presence and caters to a huge consumer base throughout the country. Buy Pain Relief Drugs & Medicines in bulk from VISWABHARATHI PHARMA at Trade India quality-assured products.
Business Type
Exporter, Distributor, Supplier, Trading Company, Wholesaler
Employee Count
5
Establishment
2009
Working Days
Monday To Sunday
GST NO
37ACZPD9181C1Z6
More Product From This seller
Seller Details
GST - 37ACZPD9181C1Z6
Kurnool, Andhra Pradesh
Proprietor
Mr Jagadesh
Address
Survey No. 680, R.T Nagar, Nagalapuram Village, Bellary Road Kurnool, Andhra Pradesh, 518463, India
Pain Relief Drugs & Medicines in Kurnool
Report incorrect details